Loading...

Evelo Biosciences, Inc.

EVLONASDAQ
Healthcare
Biotechnology
$0.001
$0.00(0.00%)

Evelo Biosciences, Inc. EVLO Peers

See (EVLO) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
EVLO$0.00+0.00%9.5KN/A-$15.64N/A
VRTX$470.13+2.54%120.7B-123.39-$3.81N/A
REGN$560.93+2.82%59.6B14.25$39.36+0.32%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$325.28+1.49%42.4B-154.93-$2.10N/A
ARGX$571.23+0.90%34.9B34.84$16.38N/A
BNTX$111.44+2.32%26.8B-29.64-$3.76N/A
RPRX$36.10+1.26%20.3B14.73$2.45+2.39%
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
SMMT$26.54+0.76%19.7B-78.06-$0.34N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EVLO vs VRTX Comparison

EVLO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EVLO stands at 9.5K. In comparison, VRTX has a market cap of 120.7B. Regarding current trading prices, EVLO is priced at $0.00, while VRTX trades at $470.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EVLO currently has a P/E ratio of N/A, whereas VRTX's P/E ratio is -123.39. In terms of profitability, EVLO's ROE is -62.33%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, EVLO is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for EVLO.

Stock Price Comparison

Loading...

Frequently Asked Questions

;